ARCHIVES

No Difference in Toxicity Between IMRT and PRT In Medicare Patients

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

Broder Issues Clinical Alert on 5-FU Levamisle Survival Advantage for Dukes C Colon Cancer

October 6, 1989

Bepler To Lead Karmanos Cancer Institute

January 29, 2010

Campus-Dweller Rabson Finds Comfort In NIH Security.

December 14, 2001

NEJM Paper Ignites Debate Over Spiral CT Scans For Lung Cancer.

November 3, 2006

FCRC Recompetition To Be Split Into Two Major Contract, For Research And “Everything Else”

September 5, 1980

Taking Profit Out Of ESAs, Insurer Sending Controversial Drugs Directly To Patients.

April 9, 2010